Federal Register of Legislation - Australian Government

Primary content

PB 98 of 2019 Determinations/Health as made
This instrument amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010) to add two drugs to F1 and moves one currently listed drug from F1 to F2.
Administered by: Health
Registered 28 Nov 2019
Tabling HistoryDate
Tabled HR02-Dec-2019
Tabled Senate02-Dec-2019
To be repealed 24 Mar 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

PB 98 of 2019

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated     27 November 2019

 

 

 

 

 

 

 

 

 

THEA DANIEL

 

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2019 (No. 11).

         (2)   This Determination may also be cited as PB 98 of 2019.

2              Commencement

                This Determination commences on 1 December 2019.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Riociguat

 

Insert

Risankizumab

 

[2]     Schedule 1, after item dealing with Secukinumab

 

Omit

Sevelamer

 

[3]     Schedule 1, after item dealing with Sodium bicarbonate

 

Insert

Sodium phenylbutyrate

 

[4]     Schedule 2, after item dealing with Sertraline

 

Insert

Sevelamer